Skip to main content
SpringerLink
Log in

Prevalence and Spectrum of p53 Mutations in White Hispanic and Non-Hispanic Women with Breast Cancer

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Hispanic women differ from non-Hispanics in breast cancer incidence, stage at diagnosis, and survival. Ethnic differences in genetic makeup, reproductive patterns, diet, socioeconomic status, physical activity, and other unidentified cultural factors may be responsible for the disparity. This study investigated occurrences of p53 tumor suppressor gene mutations in South Florida white Hispanic and white non-Hispanic women with primary breast cancer. Tumor tissues were obtained from a consecutive series of women with breast cancer who underwent breast resection at the Jackson Memorial Hospital, Miami, Florida between 1984 and 1986. A total of 231 women with primary breast cancer, aged 31–85 years, were included in the study. Among them, 64 (27.7%) were white Hispanic and 167 (72.3%) were white non-Hispanic. The majority of the patients were white non-Hispanics (72.3%). Compared to white non-Hispanics, however, white Hispanics had significantly higher proportions of tumors larger than 2 cm (53.1% v.s. 28.7%, p = 0.00) as well as larger tumor size at diagnosis (mean: 4.2 v.s. 3.0 cm, p = 0.00). The p53 gene mutation rate was significantly lower in white Hispanics than in white non-Hispanics (51.6% v.s. 70.7%, p = 0.01). Furthermore, among node-negative breast cancer patients, after adjustment for tumor size at diagnosis, logistic regression results showed that white Hispanics were 71% less likely than white non-Hispanics to carry p53 mutations (OR = 0.29 and 95% CI = 0.09–0.91). We conclude that white Hispanic women with breast cancer might have lower p53 gene mutation prevalence than white non-Hispanic women.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Zambrana RE, Carter-Pokras O: Health data issues for Hispanics: implications for public health research. J Health Care Poor U 12: 20–34, 2001

    Google Scholar 

  2. Trapido EJ, Chen F, Davis K, Lewis N, MacKinnon JA, Strait PM: Cancer in south Florida Hispanic women. A 9-year assessment. Arch Intern Med 154: 1083–1088, 1994

    Google Scholar 

  3. Shai D, Rosenwaike I: Mortality among Hispanics in metropolitan Chicago: an examination based on vital statistics data. J Chronic Dis 40: 445–451, 1987

    Google Scholar 

  4. Sorlie PD, Backlund E, Johnson NJ, Rogot E: Mortality by Hispanic status in the United States. JAMA 270: 2464–2468, 1993

    Google Scholar 

  5. Eidson M, Becker TM, Wiggins CL, Key CR, Samet JM: Breast cancer among Hispanics, American Indians and non-Hispanic whites in New Mexico. Int J Epidemiol 23: 231–237, 1994

    Google Scholar 

  6. Howe HL, Wingo PA, Thun MJ, Ries LA, Rosenberg HM, Feigal EG, Edwards BK: Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 93: 824–842, 2001

    Google Scholar 

  7. Trapido EJ, Burciaga VR, Obeso JL, Strickman-Stein N, Rotger A, Perez-Stable EJ: Epidemiology of cancer among Hispanics in the United States. J Natl Cancer Inst Monogr 17–28, 1995

  8. Miller B, Kolonel L, Bernstein L: Racial/Ethnic Patterns of Cancer in the United States 1988-1992. National Cancer Institute, Bethesda, MD, 1996

  9. Elledge RM, Clark GM, Chamness GC, Osborne CK: Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst 86: 705–712, 1994

    Google Scholar 

  10. Gilliland FD, Li YF, Baumgartner K, Crumley D, Samet JM: Physical activity and breast cancer risk in Hispanic and non-Hispanic white women. Am J Epidemiol 154: 442–450, 2001

    Google Scholar 

  11. Weston A, Godbold JH: Polymorphisms of H-ras and p53 in breast cancer and lung cancer: a meta-analysis. Environ. Health Perspect 105: 919–926, 1997

    Google Scholar 

  12. Sjalander A, Birgander R, Hallmans G, Cajander S, Lenner P, Athlin L, Beckman G, Beckman L: p53 polymorphisms and haplotypes in breast cancera. Carcinogenesis (London) 17: 1313–1316, 1996

    Google Scholar 

  13. Weston A, Pan C, Ksieski HB, Wallenstein S, Berkowitz GS, Tartter PI, Bleiweiss IJ, Brower ST, Senie RT, Wolff MS: p53 haplotype determination in breast cancer. Cancer Epidemiola Biomark Prev 6: 105–112, 1997

    Google Scholar 

  14. Weston A, WolffMS, Morabia A: True extended haplotypes of p53: indicators of breast cancer risk. Cancer Genet Cytogenet 102: 153–154, 1998

    Google Scholar 

  15. Wang-Gohrke S, Rebbeck TR, Besenfelder W, Kreienberg R, Runnebaum IB: p53 germline polymorphisms are associated with an increased risk for breast cancer in German women. Anticancer Res 18: 2095–2099, 1998

    Google Scholar 

  16. Levine AJ, Reich N, Thomas R: The regulation of a cellular protein, p53, in normal and transformed cells. Prog Clin Biol Res 119: 159–169, 1983

    Google Scholar 

  17. Hansen R, Oren M: p53, from inductive signal to cellular effect. Curr Opin Genet Dev 7: 46–51, 1997

    Google Scholar 

  18. Prives C, Hall PA: The p53 pathway. J Pathol 187: 112–126, 1999

    Google Scholar 

  19. Elledge RM, Allred DC: Prognostic and predictive value of p53 and p21 in breast cancer. Breast Cancer Res Treat 52: 79–98, 1998

    Google Scholar 

  20. Nadji M, Meng L, Lin L, Nassiri M, Morales AR: Detection of p53 gene abnormality by sequence analysis of archival paraffin tissue. A comparison with fresh-frozen specimens. Diagn Mol Pathol 5: 279–283, 1996

    Google Scholar 

  21. SAS Institute. SAS User's Guide: Statistics v6. SAS Institute, Inc., Cary, NC, 1996

    Google Scholar 

  22. Levine AJ, Chang A, Dittmer D, Notterman DA, Silver A, Thorn K, Welsh D, Wu M: The p53 tumor suppressor gene. J Lab Clin Med 123: 817–823, 1994

    Google Scholar 

  23. Harris CC, Hollstein M: Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 329: 1318–1327, 1993

    Google Scholar 

  24. Greenblatt MS, Bennett WP, Hollstein M, Harris CC: Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855–4878, 1994

    Google Scholar 

  25. Kucera E, Speiser P, Gnant M, Szabo L, Samonigg H, Hausmaninger H, Mittlbock M, Fridrik M, Seifert M, Kubista E, Reiner A, Zeillinger R, Jakesz R: Prognostic significance of mutations in the p53 gene, particularly in the zinc-binding domains, in lymph node-and steroid receptor positive breast cancer patients. Austrian Breast Cancer Study Group. Eur J Cancer 35: 398–405, 1999

    Google Scholar 

  26. Tsuda H, Hirohashi S: Association among p53 gene mutation, nuclear accumulation of the p53 protein and aggressive phenotypes in breast cancer. Int J Cancer 57: 498–503, 1994

    Google Scholar 

  27. Elledge RM: Assessing p53 status in breast cancer prognosis: where should you put the thermometer if you think your p53 is sick? J Natl Cancer Inst 88: 141–143, 1996

    Google Scholar 

  28. Nadji M, Meng L, Lin L, Nassiri M, Morales AR: Detection of p53 gene abnormality by sequence analysis of archival paraffin tissue. A comparison with fresh-frozen specimens. Diagn Mol Pathol 5: 279–283, 1996

    Google Scholar 

  29. Sjogren S, Inganas M, Norberg T, Lindgren A, Nordgren H, Holmberg L, Bergh J: The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. J Natl Cancer Inst 88: 173–182, 1996

    Google Scholar 

  30. International Agency for Research on Cancer: Trends in Cancer Incidence and Mortality. World Health Organization, Lyon, France, 1993

    Google Scholar 

  31. Bondy ML, Spitz MR, Halabi S, Fueger JJ, Vogel VG: Low incidence of familial breast cancer among Hispanic women. Cancer Cause Control 3: 377–382, 1992

    Google Scholar 

  32. May P, May E: Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 18: 7621–7636, 1999

    Google Scholar 

  33. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 253: 49–53, 1991

    Google Scholar 

  34. Greenblatt MS, Bennett WP, Hollstein M, Harris CC: Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855–4878, 1994

    Google Scholar 

  35. Levine AJ, Perry ME, Chang A, Silver A, Dittmer D, Wu M, Welsh D: The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis. Br J Cancer 69: 409–416, 1994

    Google Scholar 

  36. Harris CC, Hollstein M: Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 329: 1318–1327, 1993

    Google Scholar 

  37. Lai H, Lin L, Nadji M, Lai S, Trapido E, Meng L: Mutations in the p53 tumor suppressor gene and early onset breast cancer. Can Biol Treat 1: 23–27, 2002

    Google Scholar 

  38. Shao ZM, Wu J, Shen ZZ, Nguyen M: p53 mutation in plasma DNA and its prognostic value in breast cancer patients. Clin Cancer Res 7: 2222–2227, 2001

    Google Scholar 

  39. Hedeen AN, White E: Breast cancer size and stage in Hispanic American women, by birthplace: 1992-1995. Am J Public Health 91: 122–125, 2001

    Google Scholar 

  40. Menck HR, Mills PK: The influence of urbanization, age, ethnicity, and income on the early diagnosis of breast carcinoma: opportunity for screening improvement. Cancer 92: 1299–1304, 2001

    Google Scholar 

  41. Weiss SE, Tartter PI, Ahmed S, Brower ST, Brusco C, Bossolt K, Amberson JB, Bratton J: Ethnic differences in risk and prognostic factors for breast cancer. Cancer 76: 268–274, 1995

    Google Scholar 

  42. Delgado DJ, Lin WY, Coffey M: The role of Hispanic race/ethnicity and poverty in breast cancer survival. P R Health Sci J 14: 103–116, 1995

    Google Scholar 

  43. Borrayo EA, Jenkins SR: Feeling healthy: so why should Mexican-descent women screen for breast cancer? Qual Health Res 11: 812–823, 2001

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Johns Hopkins Medical Institutions, Baltimore, MD, USA

    Hong Lai

  2. Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA

    Shenghan Lai

  3. Department of Medicine, University of Miami School of Medicine, and GRECC, VA Medical Center, Miami, FL, USA

    Fangchao Ma

  4. Dapeng-Metagene Biotechnology Co., Ltd., Xian, Shaanxi, China

    Lou Meng

  5. Department of Epidemiology, University of Miami School of Medicine, Miami, FL, USA

    Edward Trapido

Authors
  1. Hong Lai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shenghan Lai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fangchao Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lou Meng
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Edward Trapido
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lai, H., Lai, S., Ma, F. et al. Prevalence and Spectrum of p53 Mutations in White Hispanic and Non-Hispanic Women with Breast Cancer. Breast Cancer Res Treat 81, 53–60 (2003). https://doi.org/10.1023/A:1025422905655

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1025422905655

Search

Navigation